...
首页> 外文期刊>European journal of pharmaceutical sciences >Improved stability of polyclonal antibodies: A case study with lyophilization-conserved antibodies raised against epitopes from the malaria parasite Plasmodium falciparum
【24h】

Improved stability of polyclonal antibodies: A case study with lyophilization-conserved antibodies raised against epitopes from the malaria parasite Plasmodium falciparum

机译:改善多克隆抗体的稳定性:用脂肪寄生虫疟原虫饲养蛋白饲养抗体的冻干抗体抗体的案例研究

获取原文
获取原文并翻译 | 示例
           

摘要

Antibodies can be produced as polyclonal (pAb) or monoclonal (mAb) liquid formulations with limited shelf-life. For pAbs, unlike mAbs, only little is known about excipients and lyophilization affecting antibody stability upon reconstitution. We used a model pAb directed against Plasmodium falciparum (Pf) pyridoxal 5'phosphate synthase 2 (Pdx2) to systemically study effects of bulking agents (amino acids, phosphate buffers, salt solutions), sugar(alcohols), surfactants and protein additions (bovine serum albumin, BSA) in liquid pAb formulations (isolated or in combinations) on the activity to detect the antigen in Pf extracts by Western blots. Repeated freeze-thaw cycles (20x) and extended room temperature storage markedly compromised pAb stability, the former being ameliorated by addition of cryoprotectants (glycerol, sucrose). Lyophilization of pure liquid pAb formulation markedly decreased antibody reactivity upon reconstitution which was not preserved by most bulking agents tested (e.g., histidine, arginine, acetate). Among the tested salt solutions (NaCl, Ringer, PBS), phosphate buffered saline had the largest lyoprotective potential, alongside sucrose, but not trehalose or maltitol. Among combinations of excipients, PBS, sucrose, low concentration BSA and Tween potently preserved PfPdx2 stability. Results for PBS were transferable to PfEnolase pAb, indicating that some of the formulations investigated here might be a lowcost solution for more general applicability to pAbs.
机译:抗体可以作为多克隆(PAB)或单克隆(MAB)液体制剂制成,具有限制保质期。对于pabs,与mAb不同,对于在重构时,仅对影响抗体稳定性的赋形剂和冻干是几乎不少的。我们使用针对疟原虫(PF)吡哆醛5'phosphate合酶2(PDX2)的模型PAB,以系统研究填充剂(氨基酸,磷酸盐缓冲液,盐溶液),糖(醇),表面活性剂和蛋白添加剂(牛血清白蛋白,BSA)在液体PAB制剂中(分离或组合)在活性中检测PF提取物中的抗原。反复冻融循环(20x)和延伸室温存储明显受损地稳定,前者通过添加冷冻保护剂(甘油,蔗糖)而改善。纯液PAB制剂的冻干在重构时显着降低了抗体反应性,所述抗体反应性在由测试的大多数批量试剂(例如,组氨酸,精氨酸,乙酸盐)保存而没有保留。在测试的盐溶液(NaCl,Ringer,PBS)中,磷酸盐缓冲盐水具有最大的延迟保护潜力,以及蔗糖,但不受海藻糖或麦芽糖醇。在赋形剂,PBS,蔗糖,低浓度BSA和TWEEN的组合中,PFPDX2稳定性均可稳定。 PBS的结果可转移到pfeNolasePab中,表明这里研究的一些制剂可能是低溶剂溶液,用于更普遍适用于PAB。

著录项

  • 来源
  • 作者单位

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Div Pharmaceut Cauerstr 4 D-91058 Erlangen Germany;

    Friedrich Alexander Univ Erlangen Nurnberg Div Pharmaceut Cauerstr 4 D-91058 Erlangen Germany;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

    Friedrich Alexander Univ Erlangen Nurnberg Inst Med Biotechnol Paul Gordan Str 3 D-91052;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号